Enzyme‐Linked Immunosorbent Assays
1University of Maryland, Baltimore, Maryland
Abstract
This unit describes six different ELISA systems for the detection of specific antibodies, soluble antigens, or cell-surface antigens. In all six systems, soluble reactants are removed from solution after specifically binding to solid-phase reactants. In the first four protocols, solid-phase reactants are prepared by adsorbing an antigen or antibody onto plastic microtiter plates; in the next two protocols, the solid-phase reactants are cell-associated molecules. In all protocols, the solid-phase reagents are incubated with secondary or tertiary reactants covalently coupled to an enzyme. Unbound conjugates are washed out and a chromogenic or fluorogenic substrate is added. As the substrate is hydrolyzed by the bound enzyme conjugate, a colored or fluorescent product is generated. Finally, the product is detected visually or with a microtiter plate reader. The amount of product generated is proportional to the amount of analysate in the test mixture. The Support Protocol can be used to optimize the different ELISAs. The second support protocol presents a method for preparing alkaline phosphatase conjugates.
Table of Contents
- Assays for Antibody Production
- Unit Introduction
- Basic Protocol: Indirect ELISA to Detect Specific Antibodies
- Alternate Protocol: Direct Competitive ELISA to Detect Soluble Antigens
- Alternate Protocol: Antibody-Sandwich ELISA to Detect Soluble Antigens
- Alternate Protocol: Double AntibodySandwich ELISA to Detect Specific Antibodies
- Alternate Protocol: Direct Cellular ELISA to Detect Cell-Surface Antigens
- Alternate Protocol: Indirect Cellular ELISA to Detect Antibodies Specific for Surface Antigens
- Support Protocol: Criss-Cross Serial-Dilution Analysis to Determine Optimal Reagent Concentrations
- Support Protocol: Preparation of AntibodyAlkaline Phosphatase Conjugates
- Reagents and Solutions
- Commentary
- Bibliography
- Figures
- Tables
Materials
Basic Protocol: Indirect ELISA to Detect Specific Antibodies
- Developing reagent: protein Aalkaline phosphatase conjugate (Sigma #P9650), protein Galkaline phosphatase conjugate (Calbiochem #539304), or anti-Ig-alkaline phosphatase conjugate (second support protocol)
- Antigen solution
- PBS (appendix 2A) containing 0.05% NaN
3 (PBSN) - Water, deionized or distilled
- Blocking buffer
- Test antibody samples
- 4-methylumbelliferyl phosphate (MUP) or p-nitrophenyl phosphate (NPP) substrate solution
- 0.5 M NaOH (optional)
- Multichannel pipet and disposable pipet tips
- Immulon 2 (Dynatech #011-010-3450), Immulon 4 (Dynatech #011-010-3850), or equivalent microtiter plates
- Plastic squirt bottles
- Microtiter plate reader (optional)spectrophotometer with 405-nm filter or spectrofluorometer (Dynatech #011-970-1900) with 365-nm excitation filter and 450-nm emission filter
Alternate Protocol: Direct Competitive ELISA to Detect Soluble Antigens
- Specific antibodyalkaline phosphatase conjugate (second support protocol)
- Standard antigen solution
- Test antigen solutions
- Round- or cone-bottom microtiter plates
Alternate Protocol: Antibody-Sandwich ELISA to Detect Soluble Antigens
- Specific antibody or immunoglobulin fraction from antiserum (units 2.7 & 2.9) or ascites fluid, or hybridoma supernatant (unit 2.6)
Alternate Protocol: Double AntibodySandwich ELISA to Detect Specific Antibodies
- Capture antibodies specific for immunoglobulin from the immunized species
- Specific antibodyalkaline phosphatase conjugate (second support protocol)
Alternate Protocol: Direct Cellular ELISA to Detect Cell-Surface Antigens
- Cell samples
- Specific antibodyalkaline phosphatase conjugate (see second support protocol)
- Wash buffer, ice-cold
- Cone- or round-bottom microtiter plates
- Sorvall H-1000B rotor (or equivalent)
Alternate Protocol: Indirect Cellular ELISA to Detect Antibodies Specific for Surface Antigens
- Positive-control antibodies (i.e., those that react with the experimental cells and are from the immunized species)
- Negative-control antibodies (i.e., those that do not react with the experimental cells)
- Test antibody solution
- Antibody or F(ab¢)
2 (against immunoglobulin from the immunized species) alkaline phosphatase conjugate (second support protocol) - Cone- or round-bottom microtiter plates
Support Protocol: Criss-Cross Serial-Dilution Analysis to Determine Optimal Reagent Concentrations
- Coating reagent
- Secondary reagent
- Developing reagent
- 17 × 100mm and 12 × 74mm test tubes
Support Protocol: Preparation of AntibodyAlkaline Phosphatase Conjugates
- >0.2 mg/ml antibody in PBS
- Alkaline phosphatase in NaCl solution (Sigma #P0905)
- 25% glutaraldehyde, EM grade (Sigma #G5882)
- PBS containing 100 mM lysine and 100 mM ethanolamine (PBSLE)
- Blocking buffer containing 2.5 mM MgCl
2 - 10-ml Sephadex G-25 column (appendix 3A)
- 0.2-µm filter
Figures
-
Figure 2.1.1Indirect ELISA to detect specific antibodies. Ag = antigen; Ab = antibody; E = enzyme.
-
Figure 2.1.2Direct competitive ELISA to detect soluble antigens. Ag = antigen; Ab = antibody; E = enzyme.
-
Figure 2.1.3Antibody-sandwich ELISA to detect antigen. Ag = antigen; Ab = antibody; E = enzyme.
-
Figure 2.1.4Double antibody-sandwich ELISA to detect specific antibodies. Ag = antigen; Ab = antibody; E = enzyme.
-
Figure 2.1.5Direct cellular ELISA to detect cell-surface antigens. Ab = antibody; E = enzyme; C= cell.
-
Figure 2.1.6Indirect cellular ELISA to detect antibodies specific for surface antigens. Ab = antibody; E = enzyme; C = cell.
-
Figure 2.1.7Results of a criss-cross serial-dilution analysis (for optimization of secondary and tertiary reactant concentrations) of an antibody-sandwich ELISA to detect antigen. The numbers in columns 1 to 11 and rows B to G represent relative fluorescence units observed for each well on a 96-well microtiter plate.
Plates were coated overnight with the capture antibody at 2 µg/ml. The secondary reactants, 4-fold serial dilutions of the homologous antigen and a non-cross-reactive heterologous antigen, were incubated on the plate 2 hr. The tertiary reactant, 2-fold serial dilutions of specific antibodyalkaline phosphatase conjugates, were incubated on the plate 2 hr. After 1 hr of incubation with the substrate MUP, the fluorescence was read in a microtiter plate spectrofluorometer.
Reagent concentrations depend upon individual assay variables that are set by the investigator. If the time of hydrolysis is set at 1 hr, the relative fluorescence at ~1000 relative fluorescence units, and the sensitivity at 780 pg/ml of homologous antigen, then 500 ng/ml of enzyme-antibody conjugate must be used in the ELISA. If, however, the assay has to detect only 3.12 ng/ml of homologous antigen, then the concentration of conjugate can be reduced to 125 ng/ml. It should be noted by comparing the homologous with the heterologous reactions (wells B5 versus B11 and D4 versus D10) that both the specificity and the signal-to-noise ratio for this assay are excellent.
Literature Cited
| Literature Cited | |
| Bartlett, W.C. and Noelle, R.J. 1987. A cell-surface ELISA to detect interleukin 4induced class II MHC expression on murine B cells. J. Immunol. Methods 105:79-85. | |
| Beatty, J.D., Beatty, B.G., and Vlahos, W.G. 1987. Measurement of monoclonal affinity by noncompetitive immunoassay. J. Immunol. Methods 100:173-179. | |
| Engvall, E. and Perlman, P. 1971. Enzyme-linked immunosorbent assay (ELISA): Quantitative assay of immunoglobulin G. Immunochemistry 8:871-879. | |
| Feit, C., Bartal, A.H., Tauber, G., Dymbort, G., and Hirshaut, Y. 1983. An enzyme-linked immunosorbent assay (ELISA) for the detection of monoclonal antibodies recognizing antigens expressed on viable cells. J. Immunol. Methods 58:301-308. | |
| Harada, N., Castle, B.E., Gorman, D.M., Itoh, N., Schreurs, J., Barrett, R.L., Howard, M., and Miyajima, A. 1990. Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding. Proc. Natl. Acad. Sci. U.S.A. 87:857-861. | |
| Jitsukawa, T., Nakajima, S., Sugawara, I., and Watanabe, H. 1989. Increased coating efficiency of antigens and preservation of original antigenic structure after coating in ELISA. J. Immunol. Methods 116:251-257. | |
| Kurstak, E. 1986. Enzyme Immunodiagnosis. Academic Press, San Diego. | |
| Linscott's Directory of Immunological and Biological Reagents, Santa Rosa, Calif. | |
| Macy, E., Kemeny, M., and Saxon, A. 1988. Enhanced ELISA: How to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours. FASEB J. 2:3003-3009. | |
| Maggio, E.T. 1981. Enzyme Immunoassay. CRC Press, Boca Raton, Fla. | |
| Quinn, A., Harrison, R., Jehanli, A.M.T., Lunt, G.G., and Walsh, S.S. 1988. An ELISA for the detection of anti-acetylcholine receptor antibodies using biotinylated -bungarotoxin. J. Immunol. Methods. 107:197-203. | |
| Rubenstein, K.E., Schneider, R.S., and Ulmann, E.L. 1972. Homogeneous enzyme immunoassay: A new immunochemical technique. Biochem. Biophys. Res. Commun. 47:846. | |
| Schots, A., Van der Leede, B.J., De Jongh, E., and Egberts, E. 1988. A method for the determination of antibody affinity using a direct ELISA. J. Immunol. Methods 109:225-233. | |
| Wang, K.C. and Leung, B.S. 1985. Fluorometric ELISA methods for rapid screening of anti-estrogen receptor antibody production in hybridoma cultures. J. Immunol. Methods 84:279. | |
| Key Reference | |
| Linscott's Directory. See above. | |
| Highly recommended publication listing sources of immunological reagents, kits, and cells/organisms, including addresses and phone numbers of commercial suppliers (updated quarterly). | |
Did you know we publish 20-30 new protocols monthly? Stay informed! Sign up for NEW PROTOCOL ALERTS.
PUBLISH YOUR PROTOCOL on CurrentProtocols.com.
Read our editors' blog for news, commentaries, and the latest developments in methods in and out of the lab.
Tools & Calculators
Your Recently Viewed Protocols
- Overview of Liquid Handling Instrumentation for High‐Throughput Screening Applications
- Flow Cytometry Analysis Using the Becton Dickinson FACS Calibur
- cDNA Expression Cloning in Mammalian Cells
- Cranial Nerves IX To XII
- Validity of Timeline Follow-Back (TLFB) for self-reported use of cannabis and other illicit substances – systematic review of the literature




Join the Conversation
Could you be more specific? What do you want to know?
hello. i need to understand how could I benifit from bacterial alkaline phosphatase
Post new comment